TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
EV to Sales: Premium Valuation
Above historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
9.58
↑ 62% above average
Average (9y)
5.91
Historical baseline
Range
High:9.58
Low:3.66
CAGR
+11.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 9.58 | +9.7% |
| 2024 | 8.74 | +47.8% |
| 2023 | 5.91 | -1.2% |
| 2022 | 5.98 | +1.1% |
| 2021 | 5.92 | +21.9% |
| 2020 | 4.86 | -0.9% |
| 2019 | 4.90 | +5.4% |
| 2018 | 4.65 | -5.2% |
| 2017 | 4.90 | +33.9% |
| 2016 | 3.66 | - |